These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 10372678

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct 15; 155(8):1113-33. PubMed ID: 8873639
    [Abstract] [Full Text] [Related]

  • 26. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May 15; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 27.
    Swedish Council on Health Technology Assessment.
    ; 2003 10 14. PubMed ID: 28876760
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Osteoporosis: preventive strategies.
    Kulak CA, Bilezikian JP.
    Int J Fertil Womens Med; 1998 10 14; 43(2):56-64. PubMed ID: 9609204
    [Abstract] [Full Text] [Related]

  • 31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 10 14; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 32. Assessment and hormonal management of osteoporosis.
    Trémollieres F.
    Climacteric; 2019 Apr 14; 22(2):122-126. PubMed ID: 30624083
    [Abstract] [Full Text] [Related]

  • 33. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct 14; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 34. Overview of the clinical usefulness of bone mineral measurements in the prevention of postmenopausal osteoporosis.
    Rozenberg S, Vandromme J, Kroll M, Praet JP, Peretz A, Ham H.
    Int J Fertil Menopausal Stud; 1995 Oct 14; 40(1):12-24. PubMed ID: 7749430
    [Abstract] [Full Text] [Related]

  • 35. Osteoporosis management in post-menopausal women.
    Christenson ES, Jiang X, Kagan R, Schnatz P.
    Minerva Ginecol; 2012 Jun 14; 64(3):181-94. PubMed ID: 22635014
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
    Palacios S.
    Curr Med Res Opin; 2010 Jul 14; 26(7):1553-63. PubMed ID: 20429824
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R, Faulds D.
    Pharmacoeconomics; 1994 Jun 14; 5(6):513-54. PubMed ID: 10147266
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP.
    Arch Intern Med; 2003 Oct 13; 163(18):2237-46. PubMed ID: 14557222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.